Blog
A Letter from GCMI Interim Executive Director Saylan Lukas – GCMI’s Continuing Commitment to Excellence in Medtech Innovation
Medtech and life science innovation is rigorous. It requires high levels of acumen and proficiency in multiple disciplines. It can also be immensely capital intensive. Tiffany Wilson founded Atlanta’s Global Center for Medical Innovation (GCMI) in 2012 to help medtech innovators de-risk their technologies, increasing their odds of successful commercialization and positive patient outcomes within…
Read MoreConnecting the Dots: Athens Career Academy Unveils Biotech Track, Shaping Real Futures for High School Students
FOR IMMEDIATE RELEASE–February 22, 2024– Athens, Georgia – The Athens Community Career Academy, part of the Clarke County School District, is ushering in a new era of education and community development with its innovative Biotechnology Track. Designed to meet the changing needs of the workforce in Athens, this program aims to prepare high school students…
Read MoreAruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication
January 16, 2024 08:00 ET| Source: Aruna Bio BOSTON and ATHENS, Ga., Jan. 16, 2024 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a pioneer in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program,…
Read MoreGeorgia Bio, Nationwide Life Science Leaders Unite To Celebrate Continued Investment In Biotech At New York Stock Exchange
Industry leaders from across the country to ring NYSE closing bell and kick off Biotech Month FOR IMMEDIATE RELEASE January 4, 2024, New York, NY – Georgia Bio, the life sciences trade association in Georgia, joined 16 fellow life science trade organizations from across the country yesterday to ring the closing bell at the New…
Read MoreCelebrating Evolution and Innovation: Our look back at 2023 and ahead to 2024
The life science industry and its innovations are always advancing, always evolving in a never ending quest to address unmet patient and clinical needs. Industry organizations like Georgia Bio may not experience the frequency of flux – driven in large part by new technologies – as the members and partner entities we serve, but when…
Read MoreLarge Majority of Americans Say Consideration of Clinical Trial Participation Should be a Part of Regular Health Care
New National Public Opinion Survey Reveals Willingness to Participate in Clinical Trials; Importance of Trials Reflecting the Population; Concerns About Sharing Personal Health Information Have Grown Arlington, VA – December 5, 2023 – According to survey findings released today, an overwhelming majority of Americans (87%) agree that health care professionals should discuss clinical trials…
Read MoreEchoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast
In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…
Read MorePutting the Tech in Bio & MedTech
The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. While generative AI is not ready to support clinical decision making, “Intelligent call centers, appointment setting,…
Read MoreLife Science Nation bringing a medtech investor event to Atlanta in early 2024
In September, Life Science Nation announced “RESI South’ in partnership with a newly formed coalition of life science associations representing Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. The conference will come to Atlanta, GA, in [early] 2024. RESI South is expected to draw a crowd of over 500 bioscience and medtech entrepreneurs…
Read MoreJohns Creek Named First “BioReady Community” in Georgia
As the life sciences sector in Georgia continues to grow at a rapid pace, the need for bioready sites grows. As just the second state in the country to formally adopt such a program, the BioReady Community program will allow Georgia’s municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify…
Read More